De Padua L - Search Results

1

Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.

Innocenti I, Fresa A, Tomasso A, Tarnani M, De Padua L, Benintende G, Pasquale R, Galli E, Morelli F, Giannarelli D, Autore F, Laurenti L. Innocenti I, et al. Among authors: de padua l. Cancers (Basel). 2023 Nov 26;15(23):5592. doi: 10.3390/cancers15235592. Cancers (Basel). 2023. PMID: 38067296 Free PMC article.

2

Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia.

Laurenti L, Piccioni P, Tarnani M, De Padua L, Garzia M, Efremov DG, Piccirillo N, Chiusolo P, Sica S, Leone G. Laurenti L, et al. Among authors: de padua l. Leuk Res. 2007 Feb;31(2):253-6. doi: 10.1016/j.leukres.2006.05.013. Epub 2006 Jul 3. Leuk Res. 2007. PMID: 16815546 Clinical Trial.

3

Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia.

Laurenti L, Tarnani M, Efremov DG, Chiusolo P, De Padua L, Sica S, Leone G. Laurenti L, et al. Among authors: de padua l. Leukemia. 2007 Aug;21(8):1819-21; author reply 1821. doi: 10.1038/sj.leu.2404703. Epub 2007 Apr 19. Leukemia. 2007. PMID: 17443222 No abstract available.

4

Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.

Laurenti L, Tarnani M, De Padua L, Efremov DG, Zini G, Garzia M, Piccirillo N, Chiusolo P, Sorà F, Innocenti I, Sica S, Leone G. Laurenti L, et al. Among authors: de padua l. Ann Hematol. 2008 Nov;87(11):891-8. doi: 10.1007/s00277-008-0527-3. Epub 2008 Jun 28. Ann Hematol. 2008. PMID: 18587576 Clinical Trial.

5

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.

Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, D'Arena G, Innocenti I, Marietti S, Efremov DG, Chiusolo P, Zini G, Sora' F, Sica S, Leone G. Laurenti L, et al. Among authors: de padua l. Ann Hematol. 2011 Jan;90(1):59-65. doi: 10.1007/s00277-010-1025-y. Epub 2010 Jul 13. Ann Hematol. 2011. PMID: 20625902

6

Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.

D'Arena G, Capalbo S, Laurenti L, Del Poeta G, Nunziata G, Deaglio S, Spinosa G, Tarnani M, De Padua L, Califano C, Ferrara F, Cascavilla N. D'Arena G, et al. Among authors: de padua l. Eur J Haematol. 2010 Dec;85(6):502-7. doi: 10.1111/j.1600-0609.2010.01527.x. Epub 2010 Nov 8. Eur J Haematol. 2010. PMID: 20846302

7

Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease.

D'Arena G, Laurenti L, Minervini MM, Deaglio S, Bonello L, De Martino L, De Padua L, Savino L, Tarnani M, De Feo V, Cascavilla N. D'Arena G, et al. Among authors: de padua l, de feo v, de martino l. Leuk Res. 2011 Mar;35(3):363-8. doi: 10.1016/j.leukres.2010.08.010. Epub 2010 Sep 28. Leuk Res. 2011. PMID: 20880586

8

Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation.

Laurenti L, De Padua L, Battendieri R, Tarnani M, Sica S, Blasi MA, Savino G, Leone G. Laurenti L, et al. Among authors: de padua l. Leuk Res. 2011 May;35(5):682-4. doi: 10.1016/j.leukres.2011.01.030. Epub 2011 Feb 18. Leuk Res. 2011. PMID: 21334067 Clinical Trial.

9

New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia.

Laurenti L, De Padua L, D'Arena G, Vannata B, Innocenti I, Tarnani M, Deaglio S, Sica S, Efremov DG, Leone G. Laurenti L, et al. Among authors: de padua l. Mini Rev Med Chem. 2011 Jun;11(6):508-18. doi: 10.2174/138955711795843374. Mini Rev Med Chem. 2011. PMID: 21561405

10

Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study.

Savino G, Battendieri R, Balia L, Colucci D, Larocca LM, Laurenti L, De Padua L, Blasi MA, Balestrazzi E. Savino G, et al. Among authors: de padua l. Cancer Sci. 2011 Aug;102(8):1565-7. doi: 10.1111/j.1349-7006.2011.01976.x. Epub 2011 Jun 23. Cancer Sci. 2011. PMID: 21564418 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters